Hoppa till innehållet

Redeye: Fortnox Q2 2023 - Preview

Redeye reduces its sales forecasts for Q2 2023, mainly as we adjust our estimates to Fortnox’s current ARR definition, negatively affecting the short-term Core Subscription growth forecasts. However, the Base Case remains unchanged, and the effect on our 2024 forecasts is minor.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera